Stockscreener 앱 받기
6.37
6.32%
-0.43
시간 외 거래:
6.36
-0.010
-0.16%
전일 마감가:
$6.80
열려 있는:
$6.73
하루 거래량:
649.64K
Relative Volume:
0.39
시가총액:
$325.87M
수익:
-
순이익/손실:
$-54.19M
주가수익비율:
-2.469
EPS:
-2.58
순현금흐름:
$-37.34M
1주 성능:
-4.21%
1개월 성능:
+12.15%
6개월 성능:
+14.98%
1년 성능:
+30.00%
1일 변동 폭
$6.35
$6.9282
1주일 범위
$6.35
$6.935
52주 변동 폭
$3.9328
$7.3236
Abeona Therapeutics Inc Stock (ABEO) Company Profile
명칭
Abeona Therapeutics Inc
전화
646-813-4701
주소
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
ABEO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
6.37 | 345.31M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-03-05 | 개시 | Oppenheimer | Outperform |
| 2024-07-03 | 개시 | H.C. Wainwright | Buy |
| 2024-05-30 | 개시 | Stifel | Buy |
| 2020-11-11 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | 개시 | B. Riley FBR | Buy |
| 2020-02-10 | 개시 | SVB Leerink | Outperform |
| 2019-12-10 | 재개 | Cantor Fitzgerald | Neutral |
| 2019-08-15 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2019-08-12 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-06-27 | 개시 | Mizuho | Buy |
| 2018-10-12 | 개시 | Mizuho | Buy |
| 2018-06-05 | 개시 | Seaport Global Securities | Buy |
| 2017-11-08 | 개시 | SunTrust | Buy |
| 2017-10-16 | 재확인 | H.C. Wainwright | Buy |
| 2017-10-11 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-10-10 | 개시 | Citigroup | Buy |
| 2017-10-05 | 재확인 | Maxim Group | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2017-07-18 | 재확인 | Maxim Group | Buy |
| 2017-06-22 | 재개 | Jefferies | Buy |
| 2017-01-06 | 개시 | Jefferies | Buy |
| 2016-09-29 | 재확인 | Maxim Group | Buy |
모두보기
Abeona Therapeutics Inc 주식(ABEO)의 최신 뉴스
10 Stocks Under $10 to Buy Now - Insider Monkey
What are Abeona Therapeutics Inc. company’s key revenue driversExpert Picks Review With Low Risk - jammulinksnews.com
Is Abeona Therapeutics Inc. a Top Dividend Stock to Watch in 2025Stock Portfolio Allocation Guidance for Volatile Markets - metal.it
AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients - GlobeNewswire
What are the latest earnings results for Abeona Therapeutics Inc.Financial News Entry Points Backed By Experts - jammulinksnews.com
What makes Abeona Therapeutics Inc. stock price move sharplyConservative Entry for High Return Setup Backed - metal.it
What is Abeona Therapeutics Inc. company’s growth strategyMaster stock selection with insider knowledge - jammulinksnews.com
What is the dividend policy of Abeona Therapeutics Inc. stockCapitalize on market shifts before others do - jammulinksnews.com
Abeona Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowTrade With Low Risk Exposure - beatles.ru
Why Abeona Therapeutics Inc. stock attracts strong analyst attentionTriple Return With Stability - metal.it
How volatile is Abeona Therapeutics Inc. stock compared to the marketBuild wealth faster with consistent investment plans - jammulinksnews.com
Should I hold or sell Abeona Therapeutics Inc. stock in 2025Build wealth with high-performing stocks - jammulinksnews.com
Intrinsic Value of Abeona Therapeutics Inc. Stock: Is It Undervalued or Overvalued - metal.it
What institutional investors are buying Abeona Therapeutics Inc. stockInvest in stocks with long-term growth potential - jammulinksnews.com
Why is Abeona Therapeutics Inc. stock attracting strong analyst attentionTrack stocks with high upside potential easily - jammulinksnews.com
What analysts say about Abeona Therapeutics Inc. stockSuperior investment outcomes - PrintWeekIndia
Abeona Therapeutics Inc. Stock Analysis and ForecastHigh-velocity capital appreciation - Autocar Professional
What drives Abeona Therapeutics Inc. stock priceFree Buy/Sell Signal Notifications - Autocar Professional
Is Abeona Therapeutics Inc. a good long term investmentExplosive earnings growth - Autocar Professional
Abeona targets treating 10–14 ZEVASKYN patients in 2025 while securing $155M PRV sale to extend runway - MSN
Abeona Therapeutics Amends Loan Agreement with Avenue - TipRanks
Abeona Therapeutics lowers loan interest rate and issues warrants in loan amendment - Investing.com Nigeria
Abeona Therapeutics lowers loan interest rate and issues warrants in loan amendment By Investing.com - Investing.com South Africa
Loss-Making Abeona Therapeutics Inc. (NASDAQ:ABEO) Set To Breakeven - simplywall.st
Abeona Therapeutics Inc (ABEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.43%
2.01%
자본화:
|
볼륨(24시간):